Clinical Trials Browser

Completed × Biliary Tract Neoplasms × camrelizumab × Clear all

NCT04720131 2024-01-30

Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms

NCT04642664 2021-06-03

ACABC

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma